Pharmacy-based CRC screening programs using FIT can improve early detection, especially in underserved communities, with effective follow-up care. Patients prefer digital updates for negative results ...

The faecal immunochemical test (FIT) detects small amounts of blood in poo, which can be a sign of bowel cancer. Bowel cancer is the second biggest cancer killer in the UK, affecting the large bowel ...

FIT outperformed cfDNA in detecting advanced precancerous colorectal lesions, showing higher sensitivity and specificity. Blood-based tests offer easier implementation and potentially higher adherence ...

John Crouchley lost about 5st (32kg) after experiencing digestive problems, before his diagnosis.

Colorectal cancer incidence and mortality have increased among younger adults in recent years, with the most significant increase seen in those ages 40 to 49. Starting FIT screening early was tied to ...

Methods We compared a noninvasive, multitarget stool DNA test with a fecal immunochemical test (FIT) in persons at average risk for colorectal cancer. The DNA test includes quantitative molecular ...

Overwhelming Majority View Encouraging Screening as an Act of Love Talking openly about colorectal cancer isn’t ...

Colorectal cancer was once considered primarily a disease of aging. But rates are now on the rise among younger adults. Since 2011, colon cancer rates among people younger than 50 have increased by ...

The Food and Drug Administration on Monday approved Guardant Health’s blood test, called Shield, to screen for colon cancer, NBC News reported. The test isn't meant to replace colonoscopies, but is ...